Alpha1-Proteinase Inhibitor (Human)

DRUG2 trials

Sponsors

Grifols Therapeutics LLC

Conditions

Alpha 1-Antitrypsin DeficiencyCystic Fibrosis

Phase 2

Alpha-1-Antitrypsin (AAT) To Treat Emphysema In AAT-Deficient Patients (EXACTLE)

CompletedNCT00263887

Grifols Therapeutics LLCAlpha 1-Antitrypsin Deficiency

Start: 2003-12-31End: 2007-01-31Updated: 2014-08-21

Deposition of Inhaled Prolastin in Cystic Fibrosis Patients

CompletedNCT00486837

Grifols Therapeutics LLCCystic Fibrosis

Start: 2003-12-31End: 2004-06-30Updated: 2014-08-21

Related Papers

The fibrinogen cleavage product Aα-Val360, a specific marker of neutrophil elastase activity in vivo.

2011-05-2647 citations

Therapeutic efficacy of α-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry.

2010-10-05130 citations

Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency.

2009-08-1374 citations